Why the study?
What is the incidence of fatal PE, non-fatal PE, and DVT after total hip replacement without routine chemical prophylaxis?
What is the incidence of fatal PE, non-fatal PE, and DVT after total hip replacement without routine chemical prophylaxis?
The fatal PE rate after total hip replacement without routine chemical prophylaxis is low (0.34%), suggesting that universal chemical prophylaxis may not be strictly necessary if alternative morbidity outweighs benefits.
Answers are grounded in this paper and cite their sources.
Low rates should not alter prophylaxis practice; hypothesis-generating for randomized trials in hip arthroplasty.
We studied 1162 consecutive total hip replacements (THR) to establish the incidence of fatal pulmonary embolism (PE), clinical non-fatal PE and deep-vein thrombosis (DVT) in the six months after surgery. Chemical thromboprophylaxis had not been routinely used. We used a validated questionnaire supplemented by post-mortem records and a review of the clinical notes. Follow-up was 100%. The death rate from PE was 0.34% (95% CI 0.09 to 0.88), with one fatal PE after discharge 40 days after operation. The clinical PE rate confirmed by imaging was 1.20% (CI 0.65 to 2.02), with 0.7% of patients readmitted. The venographically-confirmed clinical DVT rate was 1.89% (CI 1.11 to 2.76), with 1.13% readmitted. The total thromboembolic morbidity was 3.4% (95% CI 2.5% to 4.7%); prophylaxis to reduce this would be justifiable if the complications of such prophylaxis did not produce an alternative morbidity. The fatal PE rate after THR without routine chemical prophylaxis was low; a very large randomised clinical trial would be required to demonstrate directly whether any prophylactic measure could reduce this. There is a large discrepancy between the high DVT rate reported in clinical trials using universal screening venography and the symptomatic DVT rate shown in this study. We found insufficient evidence to recommend continuing thromboprophylaxis after discharge from hospital.
No takes yet. Share an insight, caveat, or question.
Warwick et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: